Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Editas Medicine $215.6 million stock offering
Davis Polk advised the sole book-running manager in connection with the $215.6 million common stock offering of 6,900…
Abbott Laboratories $1.3 billion notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million…
Acadia Healthcare $450 million high-yield notes offering
Davis Polk advised the representative of the initial purchasers of a Rule 144A/Regulation S offering by Acadia Healthcare…
Merck $4.5 billion notes offering
Davis Polk advised the representatives of the underwriters, in connection with the offering of $4.5 billion aggregate…
CryoLife $100 million convertible senior notes offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by CryoLife, Inc. of $100 million aggregate…
Genetron Holdings $256 million IPO
Davis Polk advised Genetron Holdings Limited on its SEC-registered initial public offering of 16,000,000 American Depositary…
IVERIC bio $160 million stock and warrants offering and private placement
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a…
IDEAYA Biosciences $100 million follow-on offering
Davis Polk advised the underwriters in connection with a public offering of 6,666,667 shares of common stock of IDEAYA…
Constellation Pharmaceuticals $192.5 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the …
Shockwave Medical $89.4 million stock offering
Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 1,955,000 shares of common stock for an…